» Articles » PMID: 23593075

Potential Applications of Quantum Dots in Mapping Sentinel Lymph Node and Detection of Micrometastases in Breast Carcinoma

Overview
Journal J Breast Cancer
Date 2013 Apr 18
PMID 23593075
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer cure aims at complete elimination of malignant cells and essentially requires detection and treatment of any micrometastases. Here, we present a review of the current methods in use and the potential role of the quantum dots (QDs) in detection and visualization of sentinel lymph node and micrometastases in breast cancer patients. The traditional histopathological, immunohistochemical, and reverse transcriptase polymerase chain reaction procedures being used for micrometastases detection had serious drawbacks of high false negativity, specificity variations and false positivity of the results. Photon emission fluorescence multiplexing characteristics of the quantum dots make them potentially ideal probes for studying the dynamics of cellular processes over time such as continuous tracking of cell migration, differentiation, and metastases. In breast cancer, QDs based molecular and genomic detections had an unparallel high sensitivity and specificity.

Citing Articles

Facile and Green Process to Synthesize a Three-Dimensional Network Few-Layer Graphene/Carbon Nanotube Composite for Electromagnetic Interference Shielding.

Yeh Y, Hsu K, Huang C, Liu W Polymers (Basel). 2022; 14(9).

PMID: 35567060 PMC: 9101479. DOI: 10.3390/polym14091892.


Quantum Dot-Based Simultaneous Multicolor Imaging.

Wang W, Liu Z, Lan X Mol Imaging Biol. 2019; 22(4):820-831.

PMID: 31529409 DOI: 10.1007/s11307-019-01432-4.


Hepa1-6-FLuc cell line with the stable expression of firefly luciferase retains its primary properties with promising bioluminescence imaging ability.

Li Y, Liu M, Cui J, Yang K, Zhao L, Gong M Oncol Lett. 2018; 15(5):6203-6210.

PMID: 29616102 PMC: 5876459. DOI: 10.3892/ol.2018.8132.


Quantum dots-based tissue and in vivo imaging in breast cancer researches: current status and future perspectives.

Wang L, Peng C, Chen C, Li Y Breast Cancer Res Treat. 2015; 151(1):7-17.

PMID: 25833213 PMC: 4408370. DOI: 10.1007/s10549-015-3363-x.

References
1.
Zhang C, Johnson L . Quantifying RNA-peptide interaction by single-quantum dot-based nanosensor: an approach for drug screening. Anal Chem. 2007; 79(20):7775-81. DOI: 10.1021/ac071225w. View

2.
Rhyner M, Smith A, Gao X, Mao H, Yang L, Nie S . Quantum dots and multifunctional nanoparticles: new contrast agents for tumor imaging. Nanomedicine (Lond). 2007; 1(2):209-17. DOI: 10.2217/17435889.1.2.209. View

3.
Mansel R, Fallowfield L, Kissin M, Goyal A, Newcombe R, Dixon J . Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006; 98(9):599-609. DOI: 10.1093/jnci/djj158. View

4.
Smith A, Duan H, Mohs A, Nie S . Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv Drug Deliv Rev. 2008; 60(11):1226-1240. PMC: 2649798. DOI: 10.1016/j.addr.2008.03.015. View

5.
Wu X, Liu H, Liu J, Haley K, Treadway J, Larson J . Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol. 2002; 21(1):41-6. DOI: 10.1038/nbt764. View